Fiorella Altruda
Overview
Explore the profile of Fiorella Altruda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
3139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F, et al.
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858515
Chronic hepatobiliary damage progressively leads to fibrosis, which may evolve into cirrhosis and/or hepatocellular carcinoma. The fight against the increasing incidence of liver-related morbidity and mortality is challenged by a...
2.
Ammirata G, Arigoni M, Licastro D, Caviglia G, Disabato M, Zubair G, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334706
The relationship between serum 25-hydroxyvitamin D (25(OH)D) levels, genomic response to vitamin D (Vit.D), and positivity to SARS-CoV-2 remains understudied. In this pilot study, during the follow-up of patients with...
3.
Sorge M, Savore G, Gallo A, Acquarone D, Sbroggio M, Velasco S, et al.
EMBO Mol Med
. 2024 Sep;
16(10):2450-2484.
PMID: 39271959
Defining the molecular mechanisms underlying cardiac resilience is crucial to find effective approaches to protect the heart. A physiologic level of ROS is produced in the heart by fatty acid...
4.
Bertino F, Mukherjee D, Bonora M, Bagowski C, Nardelli J, Metani L, et al.
Cell Rep Med
. 2024 Jul;
5(7):101647.
PMID: 39019006
Congenital hydrocephalus (CH), occurring in approximately 1/1,000 live births, represents an important clinical challenge due to the limited knowledge of underlying molecular mechanisms. The discovery of novel CH genes is...
5.
Ponzone L, Audrito V, Landi C, Moiso E, Levra Levron C, Ferrua S, et al.
Mol Cancer
. 2024 May;
23(1):105.
PMID: 38755661
Background: The main drawback of BRAF/MEK inhibitors (BRAF/MEKi)-based targeted therapy in the management of BRAF-mutated cutaneous metastatic melanoma (MM) is the development of therapeutic resistance. We aimed to assess in...
6.
Ferro A, Saccu G, Mattivi S, Gaido A, Herrera Sanchez M, Haque S, et al.
Biomolecules
. 2024 Mar;
14(3).
PMID: 38540698
In recent years, EVs have emerged as promising vehicles for coding and non-coding RNAs (ncRNAs), which have demonstrated remarkable potential as biomarkers for various diseases, including chronic liver diseases (CLDs)....
7.
Manco M, Ammirata G, Petrillo S, De Giorgio F, Fontana S, Riganti C, et al.
Biomolecules
. 2024 Feb;
14(2).
PMID: 38397386
Feline leukemia virus C receptor 1a (FLVCR1a), initially identified as a retroviral receptor and localized on the plasma membrane, has emerged as a crucial regulator of heme homeostasis. Functioning as...
8.
Panella R, Petri A, Desai B, Fagoonee S, Cotton C, Nguyen P, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629051
Obesity is a growing public health problem associated with increased risk of type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease (NAFLD) and cancer. Here, we identify microRNA-22 (miR-22) as...
9.
Saccu G, Menchise V, Gai C, Bertolin M, Ferrari S, Giordano C, et al.
Cells
. 2022 Dec;
11(23).
PMID: 36497151
Severe corneal damage leads to complete vision loss, thereby affecting life quality and impinging heavily on the healthcare system. Current clinical approaches to manage corneal wounds suffer from severe drawbacks,...
10.
Arina P, Sorge M, Gallo A, Di Mauro V, Vitale N, Cappello P, et al.
Shock
. 2022 Mar;
57(6):318-325.
PMID: 35271535
Aim: Sepsis-induced cardiomyopathy is commonplace and carries an increased risk of death. Melusin, a cardiac muscle-specific chaperone, exerts cardioprotective function under varied stressful conditions through activation of the AKT pathway....